# FDA 483 - Ghiath M. Mikdadi, M.D. - April 27, 2026

Source: https://www.keypedia.com/records/483/ghiath-m-mikdadi-md/b3451a06-b2f6-4cff-89f7-452cd4ebac3b

> FDA 483 for Ghiath M. Mikdadi, M.D. on April 27, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ghiath M. Mikdadi, M.D.
- Inspection Date: 2026-04-27
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: An FDA inspection of Ghiath M. Mikdadi, M.D., Clinical Investigator in Hammond, LA, revealed significant deficiencies in the conduct of clinical investigations. The firm failed to adhere to investigational plans by enrolling subjects who did not meet eligibility criteria for two studies. Additionally, issues were noted with blinded staff having access to laboratory values and the failure to discontinue study treatment when a prohibited medication was initiated.

## Related Officers

- [investigator](https://www.keypedia.com/people/dana-m-klimavicz/46b8cba4-6319-4ac1-a544-8a97e52484a8)

Company: https://www.keypedia.com/companies/ghiath-m-mikdadi-md/4c78f049-7a80-49f0-a7f8-894e6476ec54

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea